Compare OPBK & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPBK | LUCD |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | 249 | 82 |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.9M | 206.0M |
| IPO Year | 2018 | 2021 |
| Metric | OPBK | LUCD |
|---|---|---|
| Price | $14.32 | $1.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $16.50 | $4.13 |
| AVG Volume (30 Days) | 29.2K | ★ 1.1M |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | ★ 23.74 | 16.67 |
| EPS | ★ 0.48 | N/A |
| Revenue | $3,204,000.00 | ★ $4,346,000.00 |
| Revenue This Year | $16.07 | $115.58 |
| Revenue Next Year | $11.60 | $130.54 |
| P/E Ratio | $29.92 | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $12.41 | $0.90 |
| 52 Week High | $15.27 | $1.63 |
| Indicator | OPBK | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 54.38 |
| Support Level | $13.63 | $1.02 |
| Resistance Level | $14.95 | $1.12 |
| Average True Range (ATR) | 0.37 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 72.28 | 88.46 |
OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.